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The suppressor activity of peripheral blood mononu-
clear cells was investigated in 25 patients with psoriasis 
vulgaris. In the psoriatic patients the suppressor activity 
was found to be significantly lower than in the control 
group, which suggests that the weak suppressor activity 
may play a role in the pathogenesis of this disease. 
Several studies have been carried out r ecently to investigate 
the immunological processes which play a role in the pathogen-
esis of psoriasis vulgaris (PV), and various distw-bance of im-
mune function have been observed . It is now well known that 
suppressor T lymphocytes have an important function in the 
regulation of the immune response [1,2]. In patients with PV 
an alteration of T cell suppressor function was suspected by 
C01·mane, Hunyadi, and Hamerlinck and by Guilhou, M eyna-
dier, and Clot [3,4]. Therefore, it a ppeared to be appropriate to 
investigate the suppressor function in patients with PV. 
Various methods are employed to measm e the suppressor 
activity of peripheral blood mononuclear cells. Bresnihan a nd 
Jasin [5] observed that the peripheral blood mononuclear cells 
(PBMC) stimulated by a suboptimal concentration of concan-
avalin A (Con A) after 24 hr of incubation at 37°C exhibited 
significantly more aH-thymidine intake and secretion of newly 
synthesized protein than the cells stimulated without preincu-
bation. These differences were interpreted as a n indication of 
a depletion of short-living suppressor cells during the incubation 
period. Based on these observations these investigators devel-
oped a method to detect the suppressor function of human 
PBMC, which is widely used in clinical studies. This method 
was used he1·e to investigate the suppressor activity of PBMC 
in patients with PV. 
MATERIALS AND METHODS 
Patients 
Twenty-live untreated patients (ages 21-49, suffering from PV of the 
plaque type, duration of 7-16 yr) were involved in the present investi-
gation. None of these patients exhibited other di eases. Prior to this 
study the patients had never received either corticosteroids or im-
munosuppressive drugs. A group of 43 healthy adul ts (age 18-48) was 
used as a contro l. 
Culture Conditions and the Measurement of DNA Synthesis 
These were carried out according to the method described by Bres-
nihan and Jasi n wi th some modification (5,6). 
Briefly, leukocytes were isolated by 1 x g sedimentation from blood 
containing citrate al room temperature. Subsequently the PBM C were 
separated on Ficol-Hypaque gradients. The washed PBMC were resus-
pended in Pru·ker 199 tissue cul tu re medium, supplemented with L-
glutamine and 10% heal inactivated fet.al calf serum. Tesl cultures were 
set up in trip licate, each tube containing 3 X lOn cells in 3 ml medium. 
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The lymphocytes were stimulated with I 1-1g/ ml Con A (Serva) either 
at the initiation of the culture or after 24 hr period of incubation at 
37°C. 
The incorporation of aH- thymidine was as ayed adding 1.0 1-1Ci/ml 
"H-thymidine (1.0 Ci/mMol) to the cul tures for a 20-hr period, 76 hr 
after the addition of Con A. The radioactivi ty was measured in a Tri-
Cru·b (Packru·d) scin tillation counter. The amount of 3 H-thymidine 
incorporation into the cells was expressed as: total cpm/ 106 lympho-
cytes. 
The suppressor index (Si) was calculated using the following formula: 
Si cpm/ 10
6 lymphocytes/ preincubated for 24 hr/ 
cpm/ 106 lymphocytes/stimulated at zero hr/ 
Base lines of the unstimulated cul tures were subtracted from the counts 
of the stimulated cul tures. 
Statistics 
The significance of the difference was calculated by the Student's t-
test. 
RESULTS 
In the control group the Si yielded a range of 9.6 to 1.1 a nd 
a mean ± SEM of 3.89 ± 0.52. In the group of patients with PV 
the Si varied from 5.0 to 0.8 with a mean ± SEM of 2.32 ± 0.24 
(Figw-e). The difference between t he 2 groups proved to be 
statistically significant (p<0.05). No relationship was found 
between the extent skin lesions and t he Si. 
DISCUSSION 
Suppressor cells have been found to have an important rol e 
in in1munological tolerance, antigenic competition, genetic con-
trol of the immune responses, allotype suppression and t he 
regulation of the response to antigens. Disorders involving 
suppressor cell activity play a role in the pathogenesis of some 
humoral immunodeficiencies, ane~·gy associated with fu ngal 
infection, several autoimmune diseases and in th e immunolog-
ical enha ncement of tumor growth. 
Recent evidence obtained from studies with animals suggest-
ing that t he loss of effective suppressor T cell function can lead 
to autoimmune diseases. T he resul ts of investigations on these 
animal models of a utoimmunity suggest that similar processes 
could be characteris tic of huma n a utoimmune phenomena as 
well [1,2]. 
We utilized t he technique described by Bresnihan and Jasin 
[5] to detect the s uppressor function of PBM C in pa t ients with 
PV. This m ethod is based on t he observation that a significantly 
higher DNA and immunoglobulin synthesis are detectable in 
cultures preincubated for 24 hr at 37°C before stimulation with 
suboptimal concentration of Con A than in cul tures wit hout 
preincubation. S ince the increased responsiveness of the prein-
cubated cul tw·es cou ld be inhibi ted by the addition of a mall 
number of cells previously activated by Con A, it was suggested 
that t he enha nced reactivi ty acquiJ·ed in preincubated cul tuJ·e 
repl'esents a loss of short lived suppressor cells . In t his study, 
investigating the control group, the "H-thymidine incorporation 
detected in t he cultures preincubated for 24 hr was fo und to be 
3.89 t imes higher than in cul tures stimulated at zero hour. 
These differences are similar to t hose observed by Bresnihan 
and Jasin [5]. 
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Distribution of suppressor indices in patients with psoriasis vulgaris 
and healthy controls. The difference between the 2 groups is significant , 
p < 0.05. 
Immunological investigations of patients with PV presented 
an elevated serum and secretory IgA level, and in some patients 
an increase of serum IgE level [7-9]. It is of interest that both 
the IgA and lgE production is thymus dependent [10]. An 
antinuclear antibody was demonstrated to be present in the 
eluate of lymphocytes and granulocytes from patients with PV 
by Cormane, Hunyadi, and Hamerlinck [11). In other investi-
gations, complement-binding antibodies reactive with the mem-
brane of the horny layer cells were shown to be present in the 
sera of patients with PV [12]. These antibodies were found to 
be deposited with complement (C4 and C3) in the upper layer 
of psoriatic scales, but not in the clinically uninvolved skin of 
these patients [13]. It is assumed, therefore, that stratum cor-
neum antigens have no contact with the immune system or that 
the alteratipn of their antigenicity is necessary for immune 
complex formation [14]. These disorders could be due to an 
apparent increase in B-cell activity and could also be related 
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with the significantly decreased number of peripheral blood T 
lymphocytes as suggested by Cormane, Hunyadi, and Harner-
linck, Glinski et al, and Guilhou, Clot, and Meynadier [3,15,16]. 
In the present study the suppressor activity of peripheral 
blood mononuclear cells was found to be significantly lower in 
the group of patients with PV than in the control individuals 
(Figure). This suggests that the weak suppressor activity may 
allow the development of the increased B-cell activity and, 
together with other factors, might play a role in the pathogen-
esis of this disease. 
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